HUP0402230A2 - Többszörös bevonattal ellátott gyógyszer dózisforma - Google Patents

Többszörös bevonattal ellátott gyógyszer dózisforma

Info

Publication number
HUP0402230A2
HUP0402230A2 HU0402230A HUP0402230A HUP0402230A2 HU P0402230 A2 HUP0402230 A2 HU P0402230A2 HU 0402230 A HU0402230 A HU 0402230A HU P0402230 A HUP0402230 A HU P0402230A HU P0402230 A2 HUP0402230 A2 HU P0402230A2
Authority
HU
Hungary
Prior art keywords
coating layer
poly
methacrylic acid
methyl methacrylate
outer coating
Prior art date
Application number
HU0402230A
Other languages
English (en)
Inventor
Gregory Paul Dittmar
Joseph Michael Amante
Tony Ryan Cronk
Daniel Gary Newby
Original Assignee
The Procter & Gamble Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32823137&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0402230(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by The Procter & Gamble Co. filed Critical The Procter & Gamble Co.
Publication of HUP0402230A2 publication Critical patent/HUP0402230A2/hu
Publication of HUP0402230A3 publication Critical patent/HUP0402230A3/hu
Publication of HU231030B1 publication Critical patent/HU231030B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A találmány szilárd egységdózisformában levő gyógyászati készítményrevonatkozik, amely embernek vagy alacsonyabb rendű állatnak orálisanadagolható, és amely a következőket foglalja magában: a) egyterápiásan hatásos szer biztonságos és hatékony mennyisége; b) egybelső bevonatréteg, amelyet poli(metakrilsav, metilmetakrilát) 1:2,poli(metakrilsav, metil-metakrilát) 1:1 és ezek keverékei közülválasztanak; és c) egy külső bevonatréteg, amely egy enterálispolimert vagy filmképző bevonóanyagot tartalmaz; ahol a belsőbevonatréteg nem azonos a külső bevonatréteggel; ahol, amennyiben abelső bevonatréteg poli(metakrilsav, metilmetakrilát) 1:1, a külsőbevonatréteg poli(metakrilsav, metilmetakrilát) 1:2-től vagypoli(metakrilsav, metil-metakrilát) 1:1 és poli(metakrilsav, metil-metakrilát) 1:2 keverékétől eltérő; és ahol a belső bevonatréteg és akülső bevonatréteg semmilyen terápiásan hatásos szert nem tartalmaz. Atalálmány a továbbiakban egy terápiás szernek a gyomor-bél traktuskívánt helyére való eljuttatásának megtartására alkalmas eljárásravonatkozik a fenti készítmények embernek vagy alacsonyabb rendűállatnak való adagolásával. Ó
HU0402230A 2001-11-23 2001-11-23 Többszörös bevonattal ellátott gyógyszer dózisforma HU231030B1 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2001/043893 WO2003045356A1 (en) 2000-11-20 2001-11-23 Pharmaceutical dosage form with multiple coatings

Publications (3)

Publication Number Publication Date
HUP0402230A2 true HUP0402230A2 (hu) 2005-02-28
HUP0402230A3 HUP0402230A3 (en) 2008-04-28
HU231030B1 HU231030B1 (hu) 2019-12-30

Family

ID=32823137

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0402230A HU231030B1 (hu) 2001-11-23 2001-11-23 Többszörös bevonattal ellátott gyógyszer dózisforma

Country Status (15)

Country Link
EP (1) EP1453487B2 (hu)
JP (1) JP4999037B2 (hu)
CN (1) CN1314390C (hu)
AT (1) ATE389389T1 (hu)
AU (1) AU2002226955B2 (hu)
BR (1) BRPI0117180B8 (hu)
DE (1) DE60133319T3 (hu)
DK (1) DK1453487T3 (hu)
ES (1) ES2301575T5 (hu)
HU (1) HU231030B1 (hu)
IL (1) IL161628A (hu)
MX (1) MXPA04004747A (hu)
NZ (1) NZ532564A (hu)
PT (1) PT1453487E (hu)
WO (1) WO2003045356A1 (hu)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
US8168170B2 (en) 2002-10-03 2012-05-01 The Procter And Gamble Company Compositions having an inner core and at least three surrounding layers
GB2407501A (en) * 2003-11-03 2005-05-04 Ist Superiore Sanita Nanoparticles for delivery of a pharmacologically active agent, comprising water insoluble (co)polymer core & hydrophilic acrylate-based (co)polymer shell
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
EP1784166B1 (en) * 2004-09-01 2009-03-04 The Procter and Gamble Company Compositions comprising 5-amino-2-hydroxybenzoic acid and a reducing sugar
EP1880001B1 (en) 2005-05-31 2011-06-08 The Iams Company Feline probiotic lactobacilli
JP4938006B2 (ja) 2005-05-31 2012-05-23 ザ・アイムス・カンパニー ネコ科動物プロバイオティク・ビフィドバクテリア
WO2008093303A2 (en) 2007-02-01 2008-08-07 The Iams Company Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts
SI2152250T1 (sl) 2007-05-07 2020-06-30 Evonik Operations Gmbh Trdne dozirne oblike, ki vsebujejo enterično oplaščenje s pospešenim sproščanjem zdravila
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
GB201202433D0 (en) 2012-02-13 2012-03-28 Diurnal Ltd Controlled drug release
JP2012107058A (ja) * 2012-02-27 2012-06-07 Warner Chilcott Co Llc 複数のコーティングを有する医薬剤形
US20140141075A1 (en) * 2012-11-21 2014-05-22 Warner Chilcott Company, Llc 5-aminosalicylic acid capsule formulation
GB2510754B (en) * 2013-02-12 2016-07-13 Diurnal Ltd Controlled drug release
TWI688411B (zh) * 2013-02-22 2020-03-21 日商志瑞亞新藥工業股份有限公司 腸溶錠
JP6165022B2 (ja) * 2013-10-30 2017-07-19 株式会社ファンケル 放出制御型ソフトカプセル剤
WO2016001843A1 (en) * 2014-06-30 2016-01-07 Sun Pharmaceutical Industries Limited Extended-release gastroretentive tablets of voglibose
EP3162362A1 (de) * 2015-10-30 2017-05-03 Dr. Falk Pharma Gmbh Optimierte mesalazinhaltige hochdosistablette
CN107661370A (zh) * 2017-11-20 2018-02-06 贵州浩诚药业有限公司 一种苦参片及其制备方法
US20210113479A1 (en) * 2018-05-03 2021-04-22 M.W. Encap Limited Dosage forms for delivery of medicines to the lower gastrointestinal tract
EP3613414A1 (de) 2018-08-24 2020-02-26 Dr. Falk Pharma Gmbh Pellets mit mehrschichtiger struktur zur verzögerten freisetzung des wirkstoffs im distalen kolon
MX2021013527A (es) * 2019-05-15 2021-12-10 Evonik Operations Gmbh Proceso para preparar capsulas rellenas, de cubierta dura, con recubrimientos basados en copolimero de (met)acrilato con una maquina para llenar capsulas.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1230576B (it) * 1988-10-20 1991-10-28 Angeli Inst Spa Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon
IT1246382B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
CN1239425A (zh) * 1996-11-15 1999-12-22 普罗克特和甘保尔公司 供结肠释放的具有多层肠溶聚合物包衣的药剂
AU5310898A (en) * 1996-12-20 1998-07-17 Dumex-Alpharma A/S Release-controlled coated tablets

Also Published As

Publication number Publication date
BR0117180A (pt) 2004-11-03
BRPI0117180B1 (pt) 2018-12-04
ES2301575T3 (es) 2008-07-01
PT1453487E (pt) 2008-05-13
BRPI0117180B8 (pt) 2021-05-25
DE60133319T2 (de) 2009-04-30
CN1314390C (zh) 2007-05-09
EP1453487B2 (en) 2021-03-31
ATE389389T1 (de) 2008-04-15
CN1558754A (zh) 2004-12-29
IL161628A (en) 2014-03-31
MXPA04004747A (es) 2004-08-02
DK1453487T3 (da) 2008-07-21
NZ532564A (en) 2006-06-30
WO2003045356A1 (en) 2003-06-05
IL161628A0 (en) 2004-09-27
JP2005510539A (ja) 2005-04-21
DE60133319T3 (de) 2021-08-05
JP4999037B2 (ja) 2012-08-15
ES2301575T5 (es) 2022-04-22
AU2002226955B2 (en) 2006-04-27
AU2002226955A1 (en) 2003-06-10
HUP0402230A3 (en) 2008-04-28
DE60133319D1 (de) 2008-04-30
EP1453487A1 (en) 2004-09-08
HU231030B1 (hu) 2019-12-30
EP1453487B1 (en) 2008-03-19

Similar Documents

Publication Publication Date Title
HUP0402230A2 (hu) Többszörös bevonattal ellátott gyógyszer dózisforma
CA2359812A1 (en) Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
EP1275381A4 (en) SOLID COATED PREPARATIONS WITH TEMPERATURE RELEASE FOR ORAL ADMINISTRATION
CA2446712C (en) System for osmotic delivery of pharmaceutically active agents
JP2005515966A5 (hu)
YU36700A (sh) Oralni farmaceutski oblik za doziranje sa produženim oslobađanjem
JP2007536311A5 (hu)
HUP0301591A2 (hu) Szabályozott hatóanyag-leadású hidrokodon-készítmények
NO932979D0 (no) Orale doseringsformer med forsinket frigjoering for behandling av tarmforstyrrelser
HUP0302319A2 (hu) Gyógyszerkészítmények gyógyászati hatóanyagok szájon át történő bejuttatására
CA2277365A1 (en) Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1
WO2004108162A3 (en) Controlled release pharmaceutical composition
NO20030897L (no) Fremgangsmåte for fremstilling av farmasöytiske sammensetninger for anvendelse med blöte gelatin formuleringer
ATE549015T1 (de) Pharmazeutische wirkstoffhaltige formulierung mit überzug
JP2006104186A (ja) 感冒用医薬組成物
CA3077514C (en) Delayed release deferiprone tablets and methods of using the same
CA2433833A1 (en) Use of flumazenil in developing a drug for the treatment of alcohol dependence
JP2004537500A5 (hu)
JP5161472B2 (ja) 鎮痛用組成物
EP0787491B1 (en) Preventive and remedy for type i allergic diseases
CA2436511A1 (en) Use of flumazenil to produce a medicament for the treatment of cocaine dependency
JP2006503095A5 (hu)
WO2003018535A3 (en) Novel aminobenzoephenones
SE9902937D0 (sv) Pharmaceutical compositions
CA2444814A1 (en) Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: WARNER CHILCOTT COMPANY, LLC, US

Free format text: FORMER OWNER(S): THE PROCTER & GAMBLE CO., US